- Home
- WFF vs BOLD Comparison
WFF vs BOLD Comparison
Compare WFF & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFF
- BOLD
- Stock Information
- Founded
- WFF 1984
- BOLD 2018
- Country
- WFF Malaysia
- BOLD United States
- Employees
- WFF N/A
- BOLD N/A
- Industry
- WFF Miscellaneous manufacturing industries
- BOLD
- Sector
- WFF Consumer Discretionary
- BOLD
- Exchange
- WFF Nasdaq
- BOLD Nasdaq
- Market Cap
- WFF 22.4M
- BOLD 25.5M
- IPO Year
- WFF 2025
- BOLD 2024
- Fundamental
- Price
- WFF $0.97
- BOLD $1.30
- Analyst Decision
- WFF
- BOLD Buy
- Analyst Count
- WFF 0
- BOLD 4
- Target Price
- WFF N/A
- BOLD $4.00
- AVG Volume (30 Days)
- WFF 925.8K
- BOLD 138.1K
- Earning Date
- WFF 11-24-2025
- BOLD 11-06-2025
- Dividend Yield
- WFF N/A
- BOLD N/A
- EPS Growth
- WFF N/A
- BOLD N/A
- EPS
- WFF 0.00
- BOLD N/A
- Revenue
- WFF $4,572,290.00
- BOLD N/A
- Revenue This Year
- WFF N/A
- BOLD N/A
- Revenue Next Year
- WFF N/A
- BOLD N/A
- P/E Ratio
- WFF $197.63
- BOLD N/A
- Revenue Growth
- WFF N/A
- BOLD N/A
- 52 Week Low
- WFF $0.81
- BOLD $1.00
- 52 Week High
- WFF $29.26
- BOLD $3.75
- Technical
- Relative Strength Index (RSI)
- WFF N/A
- BOLD 66.93
- Support Level
- WFF N/A
- BOLD $1.10
- Resistance Level
- WFF N/A
- BOLD $1.26
- Average True Range (ATR)
- WFF 0.00
- BOLD 0.04
- MACD
- WFF 0.00
- BOLD 0.01
- Stochastic Oscillator
- WFF 0.00
- BOLD 87.50
About WFF WF Holding Limited Ordinary Shares
WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings and other custom-made FRP products. The company uses advanced production technology and equipment and has obtained various certifications. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.